» Articles » PMID: 29164016

Insights in Public Health: Ambulatory Blood Pressure Monitoring: Underuse in Clinical Practice in Hawai'i

Overview
Date 2017 Nov 23
PMID 29164016
Citations 2
Authors
Affiliations
Soon will be listed here.
Abstract

Hypertension is one of the leading causes of death and disability worldwide. Blood pressure reduction and control are associated with reduced risk of stroke and cardiovascular disease. To achieve optimal reduction and control, reliable and valid methods for blood pressure measurement are needed. Office based measurements can result in 'white coat' hypertension, which is when a patient's blood pressure in a clinical setting is higher than in other settings, or 'masked' hypertension, which occurs when a patient's blood pressure is normal in a clinical setting, but elevated outside the clinical setting. In 2015, the US Preventative Services Task Force recommended Ambulatory Blood Pressure Monitoring (ABPM) as the "best method" for measuring blood pressure, endorsing its use both for confirming the diagnosis of hypertension and for excluding 'white coat' hypertension. ABPM is a safe, painless and non-invasive test wherein patients wear a small digital blood pressure machine attached to a belt around their body and connected to a cuff around their upper arm that enables multiple automated blood pressure measurements at designated intervals (typically every 15 to 30 minutes) throughout the day and night for a specified period (eg, 24 hours). Patients can go about their typical daily activities wearing the device as much as possible, except when they are bathing, showering, or engaging in heavy exercise. Given the importance of blood pressure monitoring and control to population public health, this article provides details on the relevance and challenges of blood pressure measurement broadly then describes ABPM generally and specifically in the Hawai'i context.

Citing Articles

Advancement in the Cuffless and Noninvasive Measurement of Blood Pressure: A Review of the Literature and Open Challenges.

Khan Mamun M, Sherif A Bioengineering (Basel). 2023; 10(1).

PMID: 36671599 PMC: 9854981. DOI: 10.3390/bioengineering10010027.


Advances in Non-Invasive Blood Pressure Monitoring.

Quan X, Liu J, Roxlo T, Siddharth S, Leong W, Muir A Sensors (Basel). 2021; 21(13).

PMID: 34206457 PMC: 8271585. DOI: 10.3390/s21134273.

References
1.
White W, Gulati V . Managing hypertension with ambulatory blood pressure monitoring. Curr Cardiol Rep. 2015; 17(2):2. DOI: 10.1007/s11886-014-0556-6. View

2.
Franklin S, OBrien E, Thijs L, Asayama K, Staessen J . Masked hypertension: a phenomenon of measurement. Hypertension. 2014; 65(1):16-20. DOI: 10.1161/HYPERTENSIONAHA.114.04522. View

3.
Pickering T, James G, Boddie C, Harshfield G, Blank S, LARAGH J . How common is white coat hypertension?. JAMA. 1988; 259(2):225-8. View

4.
Pickering T, Hall J, Appel L, Falkner B, Graves J, Hill M . Recommendations for blood pressure measurement in humans and experimental animals: part 1: blood pressure measurement in humans: a statement for professionals from the Subcommittee of Professional and Public Education of the American Heart.... Circulation. 2005; 111(5):697-716. DOI: 10.1161/01.CIR.0000154900.76284.F6. View

5.
Lim S, Vos T, Flaxman A, Danaei G, Shibuya K, Adair-Rohani H . A comparative risk assessment of burden of disease and injury attributable to 67 risk factors and risk factor clusters in 21 regions, 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet. 2012; 380(9859):2224-60. PMC: 4156511. DOI: 10.1016/S0140-6736(12)61766-8. View